Designating the month of March 2008 as "MRSA Awareness Month".

Issues related to: Antibiotic exclusivity and Infectious disease control; H.R. 6432, S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 3560, QI Program Supplemental Funding Act of 2008; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to: Antibiotic exclusivity and Infectious disease control; H.R. 6432, Animal Drug User Fee Amendments Act of 2008; S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 3560, QI Program Supplemental Funding Act of 2008; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention S. Res.454, A resolution designating the month of March 2008 as "MRSA Awareness Month" H.R. 6381, Medical Device Safety Act of 2008, Issues relating to pre-emption S. 3398, Medical Device Safety Act of 2008, Issues relating to pre-emption S.3409, Drug and Device Accountability Act of 2008, Issues relating to the FDA regulation of imported medical devices S.2221, Transparency in Medical Device Pricing Act of 2007, Issues relating to cost of care H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, Issues related to drug pedigree S.3408, A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, Issues relating to comparative effectiveness

Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act H.R. 1424, Emergency Economic Stabilization Act of 2008 H Res. 988, Designating the month of March 2008 as `MRSA Awareness Month' S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision) S Res. 454, Designating the month of March 2008 as `MRSA Awareness Month'

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, the Community and Healthcare Associated Infections (CHAI) Reduction Act; S. Res. 454 and H. Res. 988, designating March 2008 as MRSA Awareness Month; Issues related to antibiotics and infectious dissease control.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to: Antibiotic exclusivity and Infectious disease control; H.R. 6432, S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 3560, QI Program Supplemental Funding Act of 2008; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistyance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res. 988 and S. Res. 454 MRSA Awareness Month. S. 3560, Q1 Program Suplemental Funding Act of 2008, provisions regarding antibiotics.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to: Antibiotic exclusivity and Infectious disease control; H.R. 6432, S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 3560, QI Program Supplemental Funding Act of 2008; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3251, Medicare Safe Needle Disposal Coverage Act of 2007, Issues related to sharps disposal S.1909, Medicare Safe Needle Disposal Coverage Act of 2007, Issues related to sharps disposal H.R. 5501, To authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to HIV/AIDS and Tuberculosis S. 2731, A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to funding for global assistance for HIV/AIDS, tuberculosis, malaria, and other diseases H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, Issues related to pedigree H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention S. Res.454, A resolution designating the month of March 2008 as "MRSA Awareness Month" H.R. 6381, Medical Device Safety Act of 2008, Issues relating to pre-emption S. 3398, Medical Device Safety Act of 2008, Issues relating to pre-emption S.3409, Drug and Device Accountability Act of 2008, Issues relating to the FDA regulation of imported medical devices H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, Issues relating to drug pedigree

Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act H.R. 1424, Emergency Economic Stabilization Act of 2008 H Res. 988, Designating the month of March 2008 as `MRSA Awareness Month' S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision) S Res. 454, Designating the month of March 2008 as `MRSA Awareness Month'

Client expense: Not reported · Firm income: $40,000

Issues related to: Antibiotic exclusivity and Infectious disease control; H.R. 6432, Animal Drug User Fee Amendments Act of 2008; S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 3560, QI Program Supplemental Funding Act of 2008; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistyance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res. 988 and S. Res. 454 MRSA Awareness Month. H. R. 6432, Animal Drug User Fee Amendments of 2008; S. 3560, Q1 Program Suplemental Funding Act of 2008, provisions regarding antibiotics.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6432, Animal Drug User Fee Amendments Act of 2008; S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, the Community and Healthcare Associated Infections (CHAI) Reduction Act; S. 3560, QI Program Supplemental Funding Act of 2008; S. Res. 454 and H. Res. 988, designating March 2008 as MRSA Awareness Month; Issues related to antibiotics and infectious dissease control.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 2029, Physician Payments Sunshine Act of 2007, Issues related to medical device company/physician relationship H.R. 5605, Physican Payments Sunshine Act of 2008, Issues related to medical device company/physician relationship H.R. 5501, To authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to HIV/AIDS and Tuberculosis S. 2731, A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to funding for global assistance for HIV/AIDS, tuberculosis, malaria, and other diseases H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, Issues related to pedigree H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention Proposals to amend Social Security Act to support hospital efforts to prevent and treat healthcare acquired infections Proposed legislation relating to the FDA regulation of imported medical devices

S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, the Community and Healthcare Associated Infections (CHAI) Reduction Act; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month; Issues related to Hatch-Waxman

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res 988 and S. Res. 454 MRSA Awareness Month.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res 988 and S. Res. 454 MRSA Awareness Month.

Client expense: Not reported · Firm income: $60,000

H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4352, To provide $30,000,000 in funding to the Department of Education to provide assistance to public school districts for the prevention of drug resistant infections, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention

Client expense: $250,000 · Firm income: Not reported

Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313

Client expense: Not reported · Firm income: $45,000

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE